Vanguard Personalized Indexing Management
ADMA icon

Vanguard Personalized Indexing Management’s ADMA Biologics ADMA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Buy
17,142
+6,049
+55% +$55.1K ﹤0.01% 1989
2026
Q1 		$99.9K Buy
+11,093
New +$175K ﹤0.01% 1947
2021
Q4 		– Sell
-17,630
Closed -$20K – 1058
2021
Q3 		$20K Buy
+17,630
New +$24.7K ﹤0.01% 972

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Personalized Indexing Management's ADMA Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its ADMA Biologics (ADMA) stake by 55% in Q2 2026, buying an estimated $55.1K and bringing the position to 17,142 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #1989.

Vanguard Personalized Indexing Management first reported a position in ADMA in Q3 2021 and has held it in 3 quarters since. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Vanguard Personalized Indexing Management held 17,142 shares of ADMA Biologics worth $143K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 6,049 ADMA Biologics shares in Q2 2026, an estimated $55.1K.
  • ADMA Biologics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1989 holding.
  • Vanguard Personalized Indexing Management first reported a position in ADMA Biologics in Q3 2021 and has held it in 3 quarters since.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.